{"id":"W2898633288","doi":"10.3747/co.25.4379","title":"Canadian Perspectives: Update on Inhibition of ALK-Positive Tumours in Advanced Non-Small-Cell Lung Cancer","year":2018,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Queen Elizabeth II Health Sciences Centre; McMaster University; Juravinski Cancer Centre; Royal Victoria Hospital; University of Alberta; Princess Margaret Cancer Centre; University of Calgary; Mount Sinai Hospital; Royal Victoria Regional Health Centre; Baker Hughes (Canada); Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; McGill University; Jewish General Hospital; William Osler Health System; BC Cancer Foundation; Spinal Cord Injury BC; Western University; Island Health; University of Toronto; BC Cancer Agency","funders":"Pfizer","keywords":"Crizotinib; Ceritinib; Alectinib; Medicine; Anaplastic lymphoma kinase; ALK inhibitor; Lung cancer; Oncology; Internal medicine; Clinical trial; Targeted therapy; Cancer; Malignant pleural effusion","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004611426,0.001546997,0.00224149,0.003397906,0.001777757,0.002969591,0.003100556,0.005719241,0.01399785],"category_scores_gemma":[0.00849152,0.0005795871,0.002043382,0.005354621,0.00144113,0.002981671,0.001551615,0.007735107,0.004931584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01743979,"about_ca_system_score_gemma":0.04235385,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.364944,"about_ca_topic_score_gemma":0.6682597,"domain_scores_codex":[0.9966695,0.0003473549,0.0003383326,0.0002116321,0.002033574,0.0003995561],"domain_scores_gemma":[0.9839376,0.001163763,0.0006692924,0.0001572995,0.01213424,0.00193788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000077418,0.00002341084,0.0001459209,0.001938215,0.00003985262,0.000106656,0.0000333268,0.000101741,0.000176829,0.001033699,0.8515454,0.1447776],"study_design_scores_gemma":[0.00004217259,0.00002081238,0.0003251126,0.00145355,0.00005135172,0.0001245154,0.00002134919,0.00001980765,0.00003546049,0.0002478084,0.9976462,0.00001180038],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002151954,0.858075,0.0003132023,0.09639771,0.02695038,0.0000689063,0.00138517,0.0001200337,0.01647442],"genre_scores_gemma":[0.002160376,0.9124584,0.001687223,0.05490124,0.01631818,0.00008472703,0.002109549,0.00005928663,0.01022098],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.635056,"threshold_uncertainty_score":0.7256395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04875350955883927,"score_gpt":0.4505188471758009,"score_spread":0.4017653376169616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}